Olshan’s Activist Practice Group Paves Way for Friendly Merger Between Landry’s & McCormick & Schmick’s

Firm News

After McCormick & Schmick’s rejected Landry’s acquisition offer in April 2011 and implemented a defensive "poison pill", Olshan’s Activist Practice Group quickly formulated a strategy that would pressure the McCormick & Schmick’s Board to either negotiate a transaction with Landry’s or conduct a sale process for the company. The Activist Practice Group navigated Landry’s through a complex and unprecedented "withhold quorum" proxy campaign. The Daily Deal reported the successful outcome.  Landry’s participated in the sale process and ultimately signed a merger agreement with McCormick & Schmick’s on November 7, 2011.

Steve Wolosky and Andrew M. Freedman led the proxy strategy from the Activist Practice Group and Steve Wolosky, Michael R. Neidell and Elizabeth R. Gonzalez led the merger negotiations and due diligence process.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.